NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine; Center for Medical Technology Policy. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington (DC): National Academies Press (US); 2013 Dec 27.

Cover of Genome-Based Diagnostics

Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary.

Show details

ROUNDTABLE ON TRANSLATING GENOMICBASED RESEARCH FOR HEALTH1

  • WYLIE BURKE (Co-Chair until June 2013), Professor and Chair, Department of Bioethics and Humanities, University of Washington, Seattle
  • GEOFFREY GINSBURG (Co-Chair from June 2013), Director, Center for Genomic Medicine, Institute for Genomic Sciences and Policy, Duke University, Durham, NC
  • SHARON TERRY (Co-Chair), President and Chief Executive Officer, Genetic Alliance, Washington, DC
  • NAOMI ARONSON, Executive Director, Technology Evaluation Center, Blue Cross and Blue Shield Association, Chicago, IL
  • EUAN ANGUS ASHLEY, Representative of the American Heart Association; Director, Center for Inherited Cardiovascular Disease, Stanford University School of Medicine, Palo Alto, CA
  • PAUL R. BILLINGS, Chief Medical Officer, Life Technologies, Carlsbad, CA
  • BRUCE BLUMBERG, Institutional Director of Graduate Medical Education, Northern California Kaiser Permanente, The Permanente Medical Group, Oakland, CA
  • DENISE E. BONDS, Medical Officer, Division of Prevention and Population Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD
  • JOANN A. BOUGHMAN, Formerly Executive Vice President, American Society of Human Genetics, Bethesda, MD
  • PAMELA BRADLEY, Staff Fellow, Personalized Medicine Staff, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD
  • PHILIP J. BROOKS, Health Scientist Administrator, Office of Rare Diseases Research, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD
  • ANN CASHION, Acting Scientific Director, National Institute of Nursing Research, National Institutes of Health, Bethesda, MD
  • C. THOMAS CASKEY, Professor, Baylor College of Medicine, Houston, TX
  • SARA COPELAND, Former Acting Chief, Genetic Services Branch, Health Resources and Services Administration, Rockville, MD
  • ROBERT B. DARNELL, President and Scientific Director, New York Genome Center; Investigator, Howard Hughes Medical Institute, Heilbrunn Cancer Professor and Senior Physician, Head, Laboratory of Molecular Neuro-Oncology, The Rockefeller University, New York, NY
  • MICHAEL J. DOUGHERTY, Director of Education, American Society of Human Genetics, Bethesda, MD
  • VICTOR DZAU, President and Chief Executive Officer, Duke University Health System; Chancellor for Health Affairs, Duke University, Durham, NC
  • W. GREGORY FEERO, Contributing Editor, Journal of the American Medical Association, Chicago, IL
  • ANDREW N. FREEDMAN, Branch Chief, Clinical and Translational Epidemiology Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD
  • JENNIFER L. HALL, Representative of the International Society for Cardiovascular Translational Research; Associate Professor of Medicine, University of Minnesota, Minneapolis
  • RICHARD J. HODES, Director, National Institute on Aging, Bethesda, MD
  • SHARON KARDIA, Professor and Chair of Epidemiology; Director, Public Health Genetics Program; Director, Life Science and Society Program; Codirector, Center for Public Health and Community Genomics, University of Michigan School of Public Health, Ann Arbor
  • MOHAMED KHAN, Representative of the American Medical Association; Leader of Radiation Oncology, Vancouver Cancer Centre, BC Cancer Agency, Vancouver, British Columbia, Canada
  • MUIN KHOURY , Director, National Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA
  • GABRIELA LAVEZZARI, Assistant Vice President, Scientific Affairs, PhRMA, Washington, DC
  • THOMAS LEHNER, Director, Office of Genomics Research Coordination, National Institute of Mental Health, Bethesda, MD
  • DEBRA G. B. LEONARD, Representative of the College of American Pathologists; Professor and Chair of Pathology and Physician Leader of Pathology and Laboratory Medicine, Fletcher Allen Health Care, University of Vermont College of Medicine, University of Vermont, Burlington
  • MICHELE A. LLOYD-PURYEAR, Representative of the Office of Rare Diseases Research; Former Senior Medical and Scientific Advisor, National Institute of Child Health & Human Development, Bethesda, MD
  • TERI A. MANOLIO, Director, Division of Genomic Medicine, National Human Genome Research Institute, Rockville, MD
  • ELIZABETH MANSFIELD, Director of the Personalized Medicine Staff, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD
  • KATHRYN McLAUGHLIN, Program Officer, National Hemophilia Program, Genetic Services Branch, Health Resources and Services Administration, Rockville, MD
  • KELLY McVEARRY, Former Senior Scientific Advisor, Health Solutions, Northrop Grumman Information Systems, Rockville, MD
  • GARRY NEIL, Former Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson, New Brunswick, NJ
  • ROBERT L. NUSSBAUM, Chief, Division of Medical Genetics, Department of Medicine and Institute of Human Genetics, University of California, San Francisco, School of Medicine
  • OLUFUNMILAYO F. OLOPADE , Walter L. Palmer Distinguished Service Professor of Medicine; Director, Center for Clinical Cancer Genetics; Associate Dean for Global Health, The University of Chicago, IL
  • MICHELLE A. PENNY, Senior Director, Translational Medicine Group, Eli Lilly and Company, Indianapolis, IN
  • AIDAN POWER, Vice President and Head PharmaTx Precision Medicine, Pfizer Inc., Groton, CT
  • VICTORIA M. PRATT, Representative of the Association for Molecular Pathology; Associate Professor of Clinical, Medical and Molecular Genetics and Director, Pharmacogenomics Diagnostic Laboratory, Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis
  • RONALD PRZYGODZKI, Associate Director for Genomic Medicine and Acting Director of Biomedical Laboratory Research and Development, Department of Veterans Affairs, Washington, DC
  • ALLEN D. ROSES, President and Chief Operating Officer, Cabernet, Shiraz and Zinfandel Pharmaceuticals; and Jefferson–Pilot Professor of Neurobiology and Genetics, Professor of Medicine (Neurology); Director, Deane Drug Discovery Institute; Senior Scholar, Fuqua School of Business, R. David Thomas Executive Training Center, Duke University, Durham, NC
  • KEVIN A. SCHULMAN, Professor of Medicine and Business Administration; Director, Center for Clinical and Genetic Economics; Associate Director, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC
  • JOAN A. SCOTT, Formerly Executive Director, National Coalition for Health Professional Education in Genetics, Lutherville, MD
  • SAM SHEKAR, Chief Medical Officer, Health IT Program, Northrop Grumman Information Systems, McLean, VA
  • KATHERINE JOHANSEN TABER, Senior Scientist, Genetics and Molecular Medicine, American Medical Association, Chicago, IL
  • DAVID VEENSTRA, Professor, Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle
  • MICHAEL S. WATSON , Executive Director, American College of Medical Genetics and Genomics, Bethesda, MD
  • DANIEL WATTENDORF , Deputy Chief, Medical Innovations, Department of the Air Force; Program Manager, Defense Advanced Research Projects Agency/Defense Sciences Office, Arlington, VA
  • CATHERINE A. WICKLUND, Past President, National Society of Genetic Counselors; Director, Graduate Program in Genetic Counseling; Associate Professor, Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL
  • JANET K. WILLIAMS, Representative of the American Academy of Nursing; Professor of Nursing, University of Iowa College of Nursing, Iowa City

Fellows

  • SEAN P. DAVID, James C. Puffer, M.D./American Board of Family Medicine Fellow
  • SAMUEL G. JOHNSON, American Association of Colleges of Pharmacy/American College of Clinical Pharmacy Anniversary Fellow

IOM Staff

  • ADAM C. BERGER, Project Director
  • SARAH H. BEACHY, Associate Program Officer
  • CLAIRE F. GIAMARIA, Research Associate (until July 2012)
  • TONIA E. DICKERSON, Senior Program Assistant

Board on Health Sciences Policy Staff

  • ANDREW M. POPE, Director
  • DONNA RANDALL, Administrative Assistant

Footnotes

1

Institute of Medicine forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution.

Copyright 2013 by the National Academy of Sciences. All rights reserved.
Bookshelf ID: NBK195904

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (818K)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...